Accelerating Clinical Trials (ACT) is holding an open competition to select a group to set up and run a sustainable pan-Canadian, distributive, single research ethics board (REB) review and approval process with strict timelines, for the initiation and conduct of multicentre randomized controlled trials (RCTs) in Canada. Information on this call for applications, and the application portal, can be found on the ACT-AEC website at: https://act-aec.ca/call-for-proposals/
Help shape the next version of the N2 Clinical Research SOPs!
In 2008, N2 launched Version 1 of the Clinical Research Standard Operating Procedures (SOPs). Since then, the Clinical...
